Korsuva™ (difelikefalin) – New drug approval
August 23, 2021 - Vifor Pharma and Cara Therapeutics announced the FDA approval of Korsuva (difelikefalin), for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD).
Download PDF
